My watch list
my.bionity.com  
Login  

From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, Charles River Laboratories Research Models and Preclinical Services including Phase I Clinical Services, are unequaled in the drug development business.

Who Our Customers Are

Our customer base includes every major pharmaceutical and biotechnology company worldwide as well as leading academic institutions and government research centers.

Why Pharmaceutical and Biotechnology Companies Outsource Drug Discovery and Development Research to Us

Outsourcing helps pharmaceutical and biotech companies put more drug candidates in the pipeline, move those compounds through the pipeline faster, and at the same time control development costs. In many cases, the research programs at pharmaceutical companies are operating at or near capacity. Outsourcing helps them pursue the development of a greater number of compounds without taking on the added capital expense of constructing new facilities, hiring new people, and outfitting new labs with expensive equipment. In addition, outsourcing allows pharmaceutical and biotech companies to focus their internal R&D assets on core activities.

More about Charles River
  • News

    Charles River Laboratories Acquires Distributed Bio

    Charles River Laboratories International, Inc. announced that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018. Based in South San Francisco, California, Di ... more

    Charles River to Acquire HemaCare

    Charles River Laboratories International, Inc. and HemaCare Corporation announced a definitive agreement for Charles River to acquire HemaCare for approximately $380 million in cash. HemaCare is a leader in the production of human-derived cellular products for the cell therapy market. The b ... more

    Charles River Laboratories to acquire French CRO

    Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing adjustments. The proposed transaction is expected to close i ... more

  • Companies

    Charles River Endotoxin Microbial Detection Europe SAS

    Charles River is the world's leading supplier of endotoxin detection products. As a global provider of rapid microbiological product solutions, our goal is to provide superior product quality and consistency to the scientific community. more

    Charles River Laboratories Clinical Services GmbH

    From our headquarters near Boston, MA, Charles River Laboratories' 7,500 employees serve clients as global providers of solutions that advance the drug discovery and development process. Our leading-edge products and services enable our clients to bring drugs to market faster and more eff ... more

    Charles River Biopharmaceutical Services GmbH

    NewLab BioQuality AG is a leading German contract service organization providing innovative and tailor-made solutions for the quality control of biopharmaceuticals. more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE